Cargando…

Nontuberculous mycobacterial pulmonary disease diagnosed by two methods: a prospective cohort study

BACKGROUND: Microbiological criteria for diagnosing nontuberculous mycobacterial pulmonary disease (NTM-PD) include positive culture results from at least two separately expectorated sputum specimens or one bronchial washing or lavage. However, the clinical similarities and differences between patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyung-Jun, Lee, Jong Hyuk, Yoon, Soon Ho, Kim, Sung A., Kim, Myoung Sil, Choi, Sun Mi, Lee, Jinwoo, Lee, Chang-Hoon, Han, Sung Koo, Yim, Jae-Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534935/
https://www.ncbi.nlm.nih.gov/pubmed/31126235
http://dx.doi.org/10.1186/s12879-019-4078-0
_version_ 1783421514258841600
author Kim, Hyung-Jun
Lee, Jong Hyuk
Yoon, Soon Ho
Kim, Sung A.
Kim, Myoung Sil
Choi, Sun Mi
Lee, Jinwoo
Lee, Chang-Hoon
Han, Sung Koo
Yim, Jae-Joon
author_facet Kim, Hyung-Jun
Lee, Jong Hyuk
Yoon, Soon Ho
Kim, Sung A.
Kim, Myoung Sil
Choi, Sun Mi
Lee, Jinwoo
Lee, Chang-Hoon
Han, Sung Koo
Yim, Jae-Joon
author_sort Kim, Hyung-Jun
collection PubMed
description BACKGROUND: Microbiological criteria for diagnosing nontuberculous mycobacterial pulmonary disease (NTM-PD) include positive culture results from at least two separately expectorated sputum specimens or one bronchial washing or lavage. However, the clinical similarities and differences between patients diagnosed by these two methods remain unclear. We compared clinical features and prognoses of patients with NTM-PD diagnosed from both specimen types. METHODS: We analysed data from patients who participated in the Seoul National University Hospital NTM-PD cohort (ClinicalTrials.gov identifier: NCT01616745). Baseline demographics, symptoms, radiographic findings, disease progression, and treatment responses were summarized and compared between patients diagnosed from sputum specimens and patients diagnosed from bronchoscopic specimens. RESULTS: Three hundred forty-seven patients were included in the analyses. Of these, 279 (80.4%) were diagnosed from two separately expectorated sputum specimens, and 68 (19.6%) were diagnosed from bronchoscopic specimens. Patients diagnosed from sputum specimens had more frequent and severe cough, sputum, postnasal drip, and high St. George’s Respiratory Questionnaire scores. However, the extent and severity of the radiographic lesions, disease progression, and treatment responses were similar for both groups. Further analysis based on the following three groups (sputum culture positive, sputum culture negative/bronchoscopy, and scanty sputum/bronchoscopy groups) suggested that the scanty sputum/bronchoscopy group appeared to have the worst prognosis in terms of both time to progression and time to culture conversion. CONCLUSIONS: Although some symptoms and quality of life were worse in patients with NTM-PD diagnosed from sputum specimens, their prognoses were similar to those of patients diagnosed by bronchoscopic specimen. We recommend bronchoscopic sampling for patients in whom NTM-PD is suspected clinically or radiographically, especially those who have no or scanty sputum. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12879-019-4078-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6534935
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65349352019-05-30 Nontuberculous mycobacterial pulmonary disease diagnosed by two methods: a prospective cohort study Kim, Hyung-Jun Lee, Jong Hyuk Yoon, Soon Ho Kim, Sung A. Kim, Myoung Sil Choi, Sun Mi Lee, Jinwoo Lee, Chang-Hoon Han, Sung Koo Yim, Jae-Joon BMC Infect Dis Research Article BACKGROUND: Microbiological criteria for diagnosing nontuberculous mycobacterial pulmonary disease (NTM-PD) include positive culture results from at least two separately expectorated sputum specimens or one bronchial washing or lavage. However, the clinical similarities and differences between patients diagnosed by these two methods remain unclear. We compared clinical features and prognoses of patients with NTM-PD diagnosed from both specimen types. METHODS: We analysed data from patients who participated in the Seoul National University Hospital NTM-PD cohort (ClinicalTrials.gov identifier: NCT01616745). Baseline demographics, symptoms, radiographic findings, disease progression, and treatment responses were summarized and compared between patients diagnosed from sputum specimens and patients diagnosed from bronchoscopic specimens. RESULTS: Three hundred forty-seven patients were included in the analyses. Of these, 279 (80.4%) were diagnosed from two separately expectorated sputum specimens, and 68 (19.6%) were diagnosed from bronchoscopic specimens. Patients diagnosed from sputum specimens had more frequent and severe cough, sputum, postnasal drip, and high St. George’s Respiratory Questionnaire scores. However, the extent and severity of the radiographic lesions, disease progression, and treatment responses were similar for both groups. Further analysis based on the following three groups (sputum culture positive, sputum culture negative/bronchoscopy, and scanty sputum/bronchoscopy groups) suggested that the scanty sputum/bronchoscopy group appeared to have the worst prognosis in terms of both time to progression and time to culture conversion. CONCLUSIONS: Although some symptoms and quality of life were worse in patients with NTM-PD diagnosed from sputum specimens, their prognoses were similar to those of patients diagnosed by bronchoscopic specimen. We recommend bronchoscopic sampling for patients in whom NTM-PD is suspected clinically or radiographically, especially those who have no or scanty sputum. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12879-019-4078-0) contains supplementary material, which is available to authorized users. BioMed Central 2019-05-24 /pmc/articles/PMC6534935/ /pubmed/31126235 http://dx.doi.org/10.1186/s12879-019-4078-0 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Kim, Hyung-Jun
Lee, Jong Hyuk
Yoon, Soon Ho
Kim, Sung A.
Kim, Myoung Sil
Choi, Sun Mi
Lee, Jinwoo
Lee, Chang-Hoon
Han, Sung Koo
Yim, Jae-Joon
Nontuberculous mycobacterial pulmonary disease diagnosed by two methods: a prospective cohort study
title Nontuberculous mycobacterial pulmonary disease diagnosed by two methods: a prospective cohort study
title_full Nontuberculous mycobacterial pulmonary disease diagnosed by two methods: a prospective cohort study
title_fullStr Nontuberculous mycobacterial pulmonary disease diagnosed by two methods: a prospective cohort study
title_full_unstemmed Nontuberculous mycobacterial pulmonary disease diagnosed by two methods: a prospective cohort study
title_short Nontuberculous mycobacterial pulmonary disease diagnosed by two methods: a prospective cohort study
title_sort nontuberculous mycobacterial pulmonary disease diagnosed by two methods: a prospective cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534935/
https://www.ncbi.nlm.nih.gov/pubmed/31126235
http://dx.doi.org/10.1186/s12879-019-4078-0
work_keys_str_mv AT kimhyungjun nontuberculousmycobacterialpulmonarydiseasediagnosedbytwomethodsaprospectivecohortstudy
AT leejonghyuk nontuberculousmycobacterialpulmonarydiseasediagnosedbytwomethodsaprospectivecohortstudy
AT yoonsoonho nontuberculousmycobacterialpulmonarydiseasediagnosedbytwomethodsaprospectivecohortstudy
AT kimsunga nontuberculousmycobacterialpulmonarydiseasediagnosedbytwomethodsaprospectivecohortstudy
AT kimmyoungsil nontuberculousmycobacterialpulmonarydiseasediagnosedbytwomethodsaprospectivecohortstudy
AT choisunmi nontuberculousmycobacterialpulmonarydiseasediagnosedbytwomethodsaprospectivecohortstudy
AT leejinwoo nontuberculousmycobacterialpulmonarydiseasediagnosedbytwomethodsaprospectivecohortstudy
AT leechanghoon nontuberculousmycobacterialpulmonarydiseasediagnosedbytwomethodsaprospectivecohortstudy
AT hansungkoo nontuberculousmycobacterialpulmonarydiseasediagnosedbytwomethodsaprospectivecohortstudy
AT yimjaejoon nontuberculousmycobacterialpulmonarydiseasediagnosedbytwomethodsaprospectivecohortstudy